Pharmacyclics Completes Patient Enrollment in Pivotal Xcytrin Phase III Trial For Brain Metastases
(PR Newswire)Pharmacyclics, Inc., announced today that patient enrollment has been completed in its pivotal international randomized controlled Phase III clinical trial of Xcytrin(R) Injection for the treatment of brain metastases, i.e., cancer that has spread to the brain from another part of the body.- Mar 14 7:30 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010314/sfw018_2.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines